Characteristics and Hospitalization Details of Patients with Advanced Parkinson’s Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan

Toru Baba, Toshiki Nozaki, Shunji Toya, Hideyuki Migita, Kairi Ri, Atsushi Takeda

Open source

DOI
10.1007/s40120-026-01016-9
Published
2026-09-04
Container
Neurology and Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40120-026-01016-9,
  title = {Characteristics and Hospitalization Details of Patients with Advanced Parkinson’s Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan},
  author = {Toru Baba and Toshiki Nozaki and Shunji Toya and Hideyuki Migita and Kairi Ri and Atsushi Takeda},
  year = {2026},
  journal = {Neurology and Therapy},
  doi = {10.1007/s40120-026-01016-9},
  url = {https://doi.org/10.1007/s40120-026-01016-9}
}

RIS

TY  - JOUR
TI  - Characteristics and Hospitalization Details of Patients with Advanced Parkinson’s Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan
AU  - Toru Baba
AU  - Toshiki Nozaki
AU  - Shunji Toya
AU  - Hideyuki Migita
AU  - Kairi Ri
AU  - Atsushi Takeda
PY  - 2026
JO  - Neurology and Therapy
DO  - 10.1007/s40120-026-01016-9
UR  - https://doi.org/10.1007/s40120-026-01016-9
ER  - 

APA

Baba, T., Nozaki, T., Toya, S., Migita, H., Ri, K., & Takeda, A. (2026). Characteristics and Hospitalization Details of Patients with Advanced Parkinson’s Disease Receiving Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa: Real-World First-Year Descriptive Study from Japan. Neurology and Therapy. https://doi.org/10.1007/s40120-026-01016-9

Source records